MOTS-c Benefits: A Review of the Evidence Published to Date
So far, the documented MOTS-c benefits are metabolic. In mice, the peptide blocked diet-induced obesity and insulin resistance and lifted physical performance at every age studied. The single completed human trial tested an analogue, CB4211, which reduced liver enzymes across four weeks. A phase 2a trial of MOTS-c itself is now recruiting, which means its benefits and side effects in people remain mostly unmeasured.
Shop MOTS-c Australia and Get to Know the Peptide
The name MOTS-c is short for mitochondrial open reading frame of the 12S rRNA type-c. This 16-amino-acid peptide, MRWQEMGYIFYPRKLR, is coded by the mitochondrial genome rather than the nucleus, sitting within the gene for 12S ribosomal RNA. Changhan Lee, Pinchas Cohen and their University of Southern California colleagues reported it in Cell Metabolism in 2015, making it the second mitochondrial-derived peptide identified after humanin.
Its source is what makes scientists so curious. For decades, mitochondria were viewed as power stations following instructions from the nucleus. MOTS-c offered some of the first evidence that they also issue their own hormone-like signals, and its short, clearly defined sequence makes it straightforward to synthesise and investigate. You can buy MOTS-c online in Australia in 10, 20 or 40 mg vials, each lot checked by mass spectrometry and HPLC.
Order MOTS-c for Research Into the Folate Cycle and AMPK
According to the 2015 paper, skeletal muscle is the peptide's principal target. Within the cell, MOTS-c suppresses the folate cycle along with the linked de novo purine synthesis. As a result AICAR accumulates, and this intermediate switches on AMP-activated protein kinase (AMPK), the cell's chief sensor of energy stress. Once AMPK is active, glucose uptake and fatty acid use rise, placing MOTS-c on the same pathway highlighted by many exercise and metformin studies.
In a later paper, Kim and colleagues (Cell Metabolism, 2018) demonstrated that during metabolic stress, glucose restriction for example, MOTS-c travels into the nucleus in an AMPK-dependent manner and controls nuclear genes, among them antioxidant-response genes governed by NRF2. The idea that a mitochondrial peptide could directly tune nuclear gene expression is what caught the field's attention. MOTS-c for sale in Australia at NovaPep ships from local stock with tracked delivery for this kind of signalling work.
Buy MOTS-c Online With a Clear Picture of the Animal Study Benefits
Nearly every claim about mots-c peptide benefits found online traces back to two mouse studies.
- Lee et al., Cell Metabolism, 2015. Treatment with MOTS-c stopped obesity and insulin resistance caused by a high-fat diet, and reversed insulin resistance in muscle that develops with age.
- Reynolds et al., Nature Communications, 2021. MOTS-c enhanced physical performance in mice that were young (2 month), middle-aged (12 month) and old (22 month). When intermittent treatment began late in life, at 23.5 months, physical capacity and healthspan measures improved. The paper also showed that exercise increases MOTS-c in human skeletal muscle and blood.
That final observation is where the "exercise mimetic" tag comes from. It accurately describes the mouse results. It does not show that dosing MOTS-c recreates exercise in humans, and most MOTS-c marketing operates in the space between those two claims.
Order MOTS-c Knowing Where the Human Data Stands, From CB4211 to the First Native Trial
CohBar's CB4211, an analogue engineered with better properties than the natural peptide, is the only MOTS-c-based drug to finish a human trial. During the phase 1b portion of a phase 1a/1b study (ClinicalTrials.gov NCT03998514), 20 obese participants with nonalcoholic fatty liver disease were given CB4211 or placebo through daily subcutaneous injection for four weeks. In 2021 CohBar announced that the drug was well tolerated without serious adverse events, that ALT and AST dropped 25 and 17 percent versus placebo, and that glucose declined, with body weight trending lower. These were exploratory endpoints from a brief, small trial of an altered molecule.
Native MOTS-c began its own trial in 2026. Hudson Biotech is sponsoring a phase 2a study (NCT07505745), recruiting in China from February 2026, that plans to randomise about 120 adults with prediabetes plus overweight or obesity to MOTS-c or placebo for 12 weeks. Its primary outcomes are insulin sensitivity (Matsuda index) and treatment-emergent adverse events. No results had been posted when this page was written.
Buy Verified MOTS-c Rather Than Trusting Side Effect Lists or Before and After Claims
Because no human safety dataset for native MOTS-c has been published, any catalogue of mots-c side effects is speculation. A few things are known. CB4211 produced no serious adverse events in its brief trial, the mouse studies recorded no toxicity, and since MOTS-c works through AMPK and glucose handling, blood glucose is the clear variable a sound study would track. Injection-site reactions apply to any injected peptide in general. The Hudson Biotech trial will be the first to record adverse events for MOTS-c itself.
The same goes for mots-c before and after posts. No human study has released before and after data on body composition or performance for MOTS-c. Photos and forum diaries lack a control group and verified material, and they typically involve several other compounds at once. In our opinion MOTS-c ranks among the most scientifically compelling peptides available, which is precisely why it should be studied using verified material and proper controls instead of being marketed with transformation photos.
Shop MOTS-c for Sale for Laboratory Work
NovaPep offers MOTS-c in 10 mg, 20 mg and 40 mg lyophilised vials. The biggest fill suits extended protocols, where using a single lot throughout the study holds variables constant. As with most lyophilised peptides, store it frozen or refrigerated and shielded from light. Our peptide storage guide covers the specifics, and the MOTS-c reconstitution calculator works out concentrations.
Labs developing mitochondrial models frequently pair MOTS-c with SS-31, the cardiolipin-targeting peptide, or with NAD+ for redox and sirtuin work. SLU-PP-332, a small molecule, acts on a separate exercise pathway through the estrogen-related receptors, as our SLU-PP-332 explainer describes. Our complete mitochondrial research range brings them all together. Order SS-31 online in Australia as a 10 mg vial for those paired mitochondrial arms.
Every one of these products is sold to adults 18+ for laboratory research only, not for human or veterinary use, and no part of this page is dosing advice.
Buy MOTS-c Online in Australia for Mitochondrial Research
The research described here relied on defined doses of a synthetic 16 amino acid peptide, which is exactly what NovaPep supplies. Order MOTS-c online in 10mg, 20mg or 40mg vials, and read the lot certificate before you check out. Larger fills bring the cost per milligram down, so the 40mg vial is the best value per milligram. Add bacteriostatic water to your cart, or browse the broader mitochondrial peptides range. You will not find a MOTS-c stockist near me in a shopfront, because our Australian stock is sold online.
MOTS-c Benefits: A Review of the Evidence Published to Date FAQ
What exactly is MOTS-c?
MOTS-c is a peptide of 16 amino acids (MRWQEMGYIFYPRKLR) coded by the mitochondrial genome inside the 12S rRNA gene. Lee and colleagues reported it in Cell Metabolism in 2015. It works chiefly on skeletal muscle, switching on AMPK via its effects on the folate cycle, and researchers study it for metabolic regulation.
Has MOTS-c shown peptide benefits in humans?
Not yet. The benefits described to date, such as protection against diet-induced obesity and insulin resistance and improved physical performance, all come from mouse research. The analogue CB4211 reduced liver enzymes in a four-week trial of 20 people, and a phase 2a trial of MOTS-c started in 2026.
Which MOTS-c side effects are known?
There is no published human safety data on native MOTS-c. The analogue CB4211 was well tolerated over four weeks without serious adverse events. Mouse research recorded no toxicity. Since MOTS-c influences glucose handling through AMPK, shifts in glucose are the main theoretical issue researchers would watch.
Do MOTS-c before and after results exist?
Not from controlled studies. No human trial has released before and after data on MOTS-c. Mouse work shows better treadmill performance and reduced weight gain on a high-fat diet, but before and after photos posted online have no controls, verified material or dose records, so they cannot be meaningfully interpreted.
Are CB4211 and MOTS-c the same compound?
No. CohBar developed CB4211 as a MOTS-c analogue with altered properties, and it is the molecule used in the only finished human trial. Findings for CB4211 should not be assumed to hold for native MOTS-c, which is undergoing its own phase 2a trial registered as NCT07505745.